Cutler Group LP Dexcom Inc Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

17 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	BUY	$114.22 - $140.1 $1.02 Million - $1.25 Million	8,900 Added 1483.33%	9,500 $1,000
Q3 2023 Nov 07, 2023	SELL	$86.06 - $137.93 $103,272 - $165,516	-1,200 Reduced 66.67%	600 $8,000
Q2 2023 Jul 18, 2023	SELL	$112.47 - $130.98 $821,031 - $956,153	-7,300 Reduced 80.22%	1,800 $6,000
Q1 2023 May 01, 2023	SELL	$104.0 - $122.92 $1.7 Million - $2 Million	-16,300 Reduced 64.17%	9,100 $52,000
Q4 2022 Feb 07, 2023	BUY	$84.98 - $122.67 $1.3 Million - $1.88 Million	15,300 Added 151.49%	25,400 $21,000
Q3 2022 Oct 25, 2022	SELL	$76.35 - $94.18 $53,444 - $65,926	-700 Reduced 6.48%	10,100 $166,000
Q2 2022 Aug 04, 2022	SELL	$67.99 - $132.89 $292,357 - $571,426	-4,300 Reduced 28.48%	10,800 $323,000
Q1 2022 Apr 14, 2022	BUY	$94.08 - $130.2 $1.33 Million - $1.84 Million	14,100 Added 1410.0%	15,100 $174,000
Q4 2021 Jan 18, 2022	SELL	$129.87 - $162.82 $571,428 - $716,408	-4,400 Reduced 81.48%	1,000 $43,000
Q3 2021 Oct 26, 2021	BUY	$106.71 - $143.18 $576,234 - $773,172	5,400 New	5,400 $93,000
Q1 2020 May 07, 2020	SELL	$47.79 - $75.63 $181,602 - $287,394	-3,800 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$35.53 - $43.8 $135,014 - $166,440	3,800 New	3,800 $6,000
Q4 2018 Feb 05, 2019	SELL	$26.99 - $37.37 $67,475 - $93,425	-2,500 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$23.35 - $36.72 $58,375 - $91,800	2,500 New	2,500 $3,000
Q1 2018 May 11, 2018	SELL	$13.06 - $18.54 $13,060 - $18,540	-1,000 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$11.12 - $15.38 $73,392 - $101,508	-6,600 Reduced 86.84%	1,000 $5,000
Q3 2017 Oct 17, 2017	BUY	$11.36 - $18.98 $86,336 - $144,248	7,600	7,600 $28,000

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account